NIMC
AZN icon

NWQ Investment Management Company’s AstraZeneca AZN Stock Holding History

NWQ Investment Management Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$30.6M Sell
278,911
-39,117
-12% -$4.35M 1.38% 18
2020
Q2 		$33.6K Sell
318,028
-11,391
-3% -$1.18M 1.12% 15
2020
Q1 		$29.4M Buy
329,419
+3,995
+1% +$376K 1.18% 21
2019
Q4 		$32.5M Sell
325,424
-7,335
-2% -$691K 0.81% 47
2019
Q3 		$29.7M Sell
332,759
-27,842
-8% -$2.41M 0.72% 57
2019
Q2 		$29.8M Buy
360,601
+50,525
+16% +$3.96M 0.67% 66
2019
Q1 		$25.1M Buy
310,076
+57,994
+23% +$4.57M 0.55% 85
2018
Q4 		$19.1M Sell
252,082
-33,689
-12% -$2.63M 0.45% 93
2018
Q3 		$22.6M Sell
285,771
-17,573
-6% -$1.33M 0.45% 91
2018
Q2 		$21.3M Buy
303,344
+3,245
+1% +$233K 0.38% 99
2018
Q1 		$21.1M Buy
300,099
+2,349
+0.8% +$163K 0.34% 99
2017
Q4 		$20.7M Buy
297,750
+8,812
+3% +$594K 0.27% 113
2017
Q3 		$19.6M Buy
288,938
+41,350
+17% +$2.61M 0.24% 114
2017
Q2 		$16.9M Sell
247,588
-107,880
-30% -$7.04M 0.23% 116
2017
Q1 		$22.1M Sell
355,468
-117,117
-25% -$6.82M 0.29% 105
2016
Q4 		$25.8M Buy
472,585
+52,677
+13% +$2.99M 0.35% 95
2016
Q3 		$27.6M Buy
419,908
+133,415
+47% +$8.72M 0.4% 86
2016
Q2 		$17.3M Buy
286,493
+33,100
+13% +$1.92M 0.3% 96
2016
Q1 		$14.3M Sell
253,393
-4,715
-2% -$283K 0.22% 103
2015
Q4 		$17.5M Buy
258,108
+12,840
+5% +$842K 0.27% 97
2015
Q3 		$15.6M Buy
245,268
+92,013
+60% +$6.05M 0.24% 102
2015
Q2 		$9.76M Buy
153,255
+100,990
+193% +$6.91M 0.14% 111
2015
Q1 		$3.58M Sell
52,265
-14,175
-21% -$985K 0.04% 135
2014
Q4 		$4.68M Buy
66,440
+1,965
+3% +$141K 0.06% 129
2014
Q3 		$4.61M Hold
64,475
– – 0.05% 137
2014
Q2 		$4.79M Sell
64,475
-20,975
-25% -$1.52M 0.05% 129
2014
Q1 		$5.54M Hold
85,450
– – 0.05% 122
2013
Q4 		$5.07M Sell
85,450
-400
-0.5% -$21.7K 0.04% 125
2013
Q3 		$4.46M Hold
85,850
– – 0.04% 118
2013
Q2 		$4.06M Buy
+85,850
New +$4.37M 0.04% 115

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NWQ Investment Management Company's AZN Position: Q3 2020 in Review

NWQ Investment Management Company reduced its AstraZeneca (AZN) stake by 12% in Q3 2020, selling an estimated $4.35M and leaving 278,911 shares worth $30.6M. The position accounts for 1.38% of the portfolio, ranked #18.

NWQ Investment Management Company first reported a position in AZN in Q2 2013 and has held it in 30 quarters since. The position peaked at $32.5M in Q4 2019. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • NWQ Investment Management Company held 278,911 shares of AstraZeneca worth $30.6M as of Q3 2020.
  • NWQ Investment Management Company sold 39,117 AstraZeneca shares in Q3 2020, an estimated $4.35M.
  • AstraZeneca made up 1.38% of NWQ Investment Management Company's portfolio in Q3 2020, its #18 holding.
  • NWQ Investment Management Company first reported a position in AstraZeneca in Q2 2013 and has held it in 30 quarters since.
  • NWQ Investment Management Company's AstraZeneca position peaked at $32.5M in Q4 2019.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.